Significance of C4d deposition in antibody-mediated rejection

Clinical Transplantation

Volumn 26, Issue SUPPL.24, 2012, Pages 43-48

  Takeda, Asami ^a   Otsuka, Yasuhiro ^a   Horike, Keiji ^a   Inaguma, Daijo ^a   Hiramitsu, Takahisa ^a   Yamamoto, Takayuki ^a   Nanmoku, Koji ^a   Goto, Norihiko ^a   Watarai, Yoshihiko ^a   Uchida, Kazuharu ^a   Morozumi, Kunio ^a   Kobayashi, Takaaki ^b  

^a NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antibody mediated reaction; C4d; Donor specific antibody; Kidney transplantation; Transplant glomerulopathy

Indexed keywords

COMPLEMENT COMPONENT C4D; RITUXIMAB;

ACUTE DISEASE; ANTIBODY MEDIATED REJECTION; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CHRONIC DISEASE; CLINICAL ARTICLE; GLOMERULOPATHY; GLOMERULUS CAPILLARY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; KIDNEY TUBULE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPLENECTOMY;

COMPLEMENT C4B; GRAFT REJECTION; HUMANS; IMMUNITY, HUMORAL; ISOANTIBODIES; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; PEPTIDE FRAGMENTS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84863188712     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2012.01642.x     Document Type: Article

References (18)

1. Solez K, Colvin RB, Racusen LC et al. Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007: 7: 518.
2. Sis B, Mengel M, Haas M et al. Banff '09 Meeting Report: antibody mediated graft deterioration and implementation of Banff Working Groups. A J Transplant 2010: 10: 464.
3. Racusen LC, Colvin RB, Solez K et al. Antibody-mediated rejection criteria - an addition to the Banff '97 classification of renal allograft rejection. A J Transplant 2003: 3: 708.
4. Haas M, Segev DL, Racusen LC et al. C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts. J Am Soc Nephrol 2009: 20: 197.
5. Sis B, Jhangri G, Bunnag J et al. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damages despite lack of C4d staining. A J Transplant 2009: 9: 2312.
6. Aita K, Yamaguchi Y, Horita S et al. Thickening of the peritubular capillary basement membrane is a useful diagnostic marker of chronic rejection in renal allografts. Am J Transplant 2007: 7: 923.
7. Mauiyyedi S, Crespo M, Collins AB et al. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classificatio. J Am Soc Nephrol 2002: 13: 779.
8. Nickeleit V, Mihatsch MJ. Kidney transplants, antibodies and rejection: is C4d a magic marker? Nephrol Dial Transplant 2003: 18: 2232.
9. Kato M, Morozumi K, Takeuchi O et al. Complement fragment C4d deposition in peritubular capillaries in acute humoral rejection after ABO blood group-incompatible human kidney transplantation. Transplantation 2003: 15: 663.
10. Dragun D, Muller DN, Broesen JH et al. Angiotensin II type 1-receptor activating antibodies in renal allograft rejection. N Engl J Med 2005: 352: 558.
11. Loupy A, Hill GS, Suberbielle C et al. Significance of C4d banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA). A J Transplant 2011: 11: 56.
12. Einecke G, Sis B, Reeve J et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. A J Transplant 2009: 9: 2520.
13. Fotheringham J, Angel CA, Mckane W. Transplant glomerulopathy: morphology, associations and mechanism. Nephron Clin Pract 2009: 113: c1.
14. Sis B, Campbell PM, Mueller T et al. Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant 2007: 7: 1743.
15. Gllor JM, Sethi S, Stegall MD et al. Transplant glomerulopathy; subclinical incidence and association with alloantibody. Am J Transplant 2007: 7: 2124.
16. Haas M, Montogomery RA, Segev DL et al. Subclinical acute antibody-mediated rejection in positive crossmatch renal allografts. Am J Transplant 2007: 7: 576.
17. Sis B, Halloran PF. Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection. Curr Opin Organ Transplant 2010: 15: 42.
18. Hidalgo LG, Campbell PM, Sis B et al. De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. A J Transplant 2009: 9: 2532.